tadalafil has been researched along with natriuretic peptide, c-type in 2 studies
| Studies (tadalafil) | Trials (tadalafil) | Recent Studies (post-2010) (tadalafil) | Studies (natriuretic peptide, c-type) | Trials (natriuretic peptide, c-type) | Recent Studies (post-2010) (natriuretic peptide, c-type) |
|---|---|---|---|---|---|
| 1,742 | 392 | 1,089 | 1,413 | 31 | 477 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allard, M; Blair, C; Feldman, J; Gillies, H; Keogh, A; Oudiz, RJ; Shapiro, S; Tislow, J; Torres, F | 1 |
| Jia, H; Levine, MA; Qin, L; Tower, RJ; Wang, L | 1 |
1 trial(s) available for tadalafil and natriuretic peptide, c-type
| Article | Year |
|---|---|
Clinical and hemodynamic improvements after adding ambrisentan to background PDE5i therapy in patients with pulmonary arterial hypertension exhibiting a suboptimal therapeutic response (ATHENA-1).
Topics: Adult; Antihypertensive Agents; Biomarkers; Dose-Response Relationship, Drug; Drug Therapy, Combination; Elapid Venoms; Endothelin A Receptor Antagonists; Exercise Tolerance; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Male; Middle Aged; Natriuretic Peptide, C-Type; Outcome Assessment, Health Care; Phenylpropionates; Phosphodiesterase 5 Inhibitors; Pyridazines; Survival; Tadalafil; Treatment Outcome | 2017 |
1 other study(ies) available for tadalafil and natriuretic peptide, c-type
| Article | Year |
|---|---|
Analysis of short-term treatment with the phosphodiesterase type 5 inhibitor tadalafil on long bone development in young rats.
Topics: Animals; Animals, Newborn; Bone and Bones; Bone Development; Cancellous Bone; Chondrocytes; Cortical Bone; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Epiphyses; Male; Natriuretic Peptide, C-Type; Phosphodiesterase 5 Inhibitors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tadalafil; Weight Gain; X-Ray Microtomography | 2018 |